Lipid‐lowering agent vs placebo or no treatment: Ipsilateral major or disabling stroke
Lipid‐lowering agent showed no clear difference in ipsilateral major or disabling stroke (only reported for two… compared with placebo or no treatment (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Lipid‐lowering agent vs placebo or no treatment Ipsilateral major or disabling stroke (only reported for two studies: one used CT scan, MRI and hospital records/every 6 weeksb; the other used physical examination/at beginning and 10 days after the endc) · asymptomatic carotid stenosis Lipid‐lowering agent showed no clear difference in ipsilateral major or disabling stroke (only reported for two… compared with placebo or no treatment (low certainty). Pharmacological interventions for asymptomatic carotid stenosis (2023) · Cochrane Headline outcomes only | RR 0.36 [0.09, 1.53] | 5 studies · 2235 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.